Tylosin
USP/1703805 - United States Pharmacopeia (USP) Reference Standard
Synonym: Tylosin A
CAS Number: 1401-69-0
Empirical Formula (Hill Notation): C46H77NO17
Molecular Weight: 916.10
MDL Number: MFCD09753818
Linear Formula: C46H77NO17
Product Type: Chemical
| API family | tylosin |
| application(s) | USP Biologics pharmaceutical (small molecule) |
| format | neat |
| grade | pharmaceutical primary standard |
| InChI | 1S/C46H77NO17/c1-13-33-30 |
| InChI key | WBPYTXDJUQJLPQ-VMXQISHHSA |
| manufacturer/tradename | USP |
| storage temp. | 2-8°C |
| Analysis Note: | These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. |
| Application: | Tylosin USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as: • Tylosin Tartrate • Tylosin Granulated • Tylosin Injection |
| General description: | Tylosin is a macrolide antibiotic derived from Streptomyces fradiae, primarily used in veterinary medicine. It inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit and is effective against Gram-positive organisms and mycoplasmas. The USP reference standard enables quality control of tylosin-containing drug substances and finished dosage forms. The USP biologics antibiotics category includes a wide range of antimicrobial agents that are essential in treating bacterial infections. These antibiotics are derived from various natural sources or synthesized to combat specific pathogens effectively. The USP provides comprehensive standards, reference materials, and analytical procedures to ensure the identity, quality, purity, and consistency of antibiotic therapeutics throughout their lifecycle. The United States Pharmacopeia (USP) provides quality standards for biologics to ensure their safety, efficacy, and quality throughout the manufacturing process. These standards assist manufacturers in adhering to regulatory requirements and help safeguard public health by reducing risks associated with biologics. |
| Other Notes: | Sales restrictions may apply. |
| Other Notes: | This product is part of the USP Biologics program. |
| Other Notes: | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia   . |
| Symbol |   GHS08,GHS09 |
| Signal word | Danger |
| Hazard statements | H317 - H334 - H400 |
| Precautionary statements | P261 - P280 - P284 - P304 + P340 - P342 + P311 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 2 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Storage Temp. | 2-8°C |
| UNSPSC | 41116107 |